Fundraising Fox

Geoffrey Smith

Investor

Managing Partner at Digitalis Ventures Β· Board director at Grobio

New York, New York

Writes $100K – $10M checks Β· typically $1.5M

About

Geoffrey W. Smith combines biotech leadership as Alcea Therapeutics CEO with training physicians and scientists at Columbia, chairs Central European University, and founded Digitalis Commons for public-minded health innovation.

ContactΒ· self-published, not guessed

Invests in

AI & Machine LearningBiotechDeep TechDigital HealthHardwareHealthtechMedical Devices

Board director at Grobio

Intro paths

β†’

In turn, Geoffrey can intro founders to Grobio's investors below.

Co-founders at Grobio

DJ
Daniel J MandellExecutive Officer, Director

Experience

  1. Digitalis VenturesFounder/Managing Partnercurrent2016 β€” presentNew York City Metropolitan Area
  2. Digitalis CommonsFounder/Chairmancurrent2019 β€” present
  3. Digitalis LabsFounder/Director of Researchcurrent2025 β€” presentNew York, New York, United States
  4. Partnership Fund for New York CityDirectorcurrent2026 β€” presentNew York, New York, United States
  5. Salzburg Global SeminarDirectorcurrent2024 β€” present
  6. The Jackson LaboratoryTrusteecurrent2017 β€” present
  7. Icahn School of Medicine at Mount SinaiDirector, Mount Sinai Institute of Technology2013 β€” 2014New York, NY
  8. Icahn School of Medicine at Mount SinaiProfessor, Population Health Science and Policy2012 β€” 2014New York, NY
  9. The Rockefeller UniversityVisiting Scholar2006 β€” 2014New York, New York, United States

Skills & more

Lifesciences27Biotechnology38Drug Discovery18Clinical Trials13Venture Capital51Management15Oncology4Infectious Diseases4Entrepreneurship12Technology Transfer7Pharmaceutical Industry4Cancer4
+9 moreCommercializationClinical DevelopmentCell BiologyGeneticsCell CultureLife SciencesStrategyStart-upsBusiness Strategy

From Geoffrey's professional profile.

Colleagues at Digitalis Ventures

Network8

Investors connected to Geoffrey in public investor directories β€” a warm-intro map.

Frequently asked questions

Who is Geoffrey Smith?
Geoffrey W. Smith combines biotech leadership as Alcea Therapeutics CEO with training physicians and scientists at Columbia, chairs Central European University, and founded Digitalis Commons for public-minded health innovation.
Where does Geoffrey Smith work?
Geoffrey Smith is Managing Partner at Digitalis Ventures and Board director at Grobio.
What does Geoffrey Smith invest in?
Geoffrey Smith invests in AI & Machine Learning, Biotech, Deep Tech, Digital Health, Hardware, Healthtech, Medical Devices.
What check size does Geoffrey Smith write?
Geoffrey Smith typically writes checks of $100K – $10M.
Where did Geoffrey Smith go to school?
Geoffrey Smith studied at University of Pennsylvania (Doctor of Law (J.D.)); Williams College (Bachelor of Arts (B.A.)).

Same school

Shared employers